Ontology highlight
ABSTRACT:
SUBMITTER: Shuhendler AJ
PROVIDER: S-EPMC4594000 | biostudies-literature | 2015 Oct
REPOSITORIES: biostudies-literature
Shuhendler Adam J AJ Ye Deju D Brewer Kimberly D KD Bazalova-Carter Magdalena M Lee Kyung-Hyun KH Kempen Paul P Dane Wittrup K K Graves Edward E EE Rutt Brian B Rao Jianghong J
Scientific reports 20151006
Personalized cancer medicine requires measurement of therapeutic efficacy as early as possible, which is optimally achieved by three-dimensional imaging given the heterogeneity of cancer. Magnetic resonance imaging (MRI) can obtain images of both anatomy and cellular responses, if acquired with a molecular imaging contrast agent. The poor sensitivity of MRI has limited the development of activatable molecular MR contrast agents. To overcome this limitation of molecular MRI, a novel implementatio ...[more]